The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. At first a blockbuster drug, producing billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly diminishing its position . While some firms may try to capitalize on male sexual dysfunction, the